[Mechanisms of action of the new preparation mezotrin].
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D003959:Diamines / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D009206:Myocardium / Q000201:enzymology; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011943:Receptors, Adrenergic, beta / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D003959:Diamines; D007473:Ion Channels; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011976:Receptors, Muscarinic; C051404:mesotrin; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D002118:Calcium
Issledovanie mekhanizmov deĭstviia novogo preparata mezotrina.